KKR Genetic Disorder L.P.

13F Holdings History for BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

Symbol: BBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 13.3M shares
Security Ownership: 7%

KKR Genetic Disorder L.P. ownership in BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO)

2025-05-14 - KKR Genetic Disorder L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13.3M shares of BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share (BBIO). This represents 7% percent ownership of the company. In their previous filing dated 2025-03-07, KKR Genetic Disorder L.P. had reported owning 19.3M shares, indicating a decrease of -31.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
KKR Genetic Disorder L.P.	7%	-31%	$436M	13.3M	-6,000,000	-31.2%	$32.88	13D/A	5/12/2025	14 May 2025 17:52:58
KKR Genetic Disorder L.P.	10.1%		$633M	19.3M			$32.88	13D/A	3/5/2025	7 Mar 2025 18:15:29